# Alliancebernstein Holding L.P.: financial statements, quarterly

AB · NYSE · CIK 825313 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ab.md) · [Financials](/companies/ab/financials.md) · [Filings](/companies/ab/filings.md) · [Insiders](/companies/ab/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ab/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $m | [9.3 d](/filings/0000825313-26-000020.md) | [9.1](/filings/0000825313-25-000034.md) | [9.2](/filings/0000825313-25-000077.md) | [9.2](/filings/0000825313-25-000104.md) | [11.2 d](/filings/0000825313-26-000020.md) | [8.7](/filings/0000825313-26-000032.md) | [8.6](/filings/0000825313-26-000050.md) | [7.7](/filings/0000825313-26-000083.md) | [8.0 d](/filings/0000825313-26-000020.md) | [7.0](/filings/0000825313-26-000032.md) | [8.3](/filings/0000825313-26-000050.md) | [6.9](/filings/0000825313-26-000083.md) |
| Net income | $m | [79.2 d](/filings/0000825313-26-000020.md) | [77.2](/filings/0000825313-25-000034.md) | [114](/filings/0000825313-25-000077.md) | [127](/filings/0000825313-25-000104.md) | [105 d](/filings/0000825313-26-000020.md) | [74.0](/filings/0000825313-26-000032.md) | [70.2](/filings/0000825313-26-000050.md) | [73.8](/filings/0000825313-26-000083.md) | [81.8 d](/filings/0000825313-26-000020.md) | [85.2](/filings/0000825313-26-000032.md) | [71.7](/filings/0000825313-26-000050.md) | [73.1](/filings/0000825313-26-000083.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,078](/filings/0000825313-25-000014.md) | [2,069](/filings/0000825313-24-000037.md) | [2,086](/filings/0000825313-24-000060.md) | [2,099](/filings/0000825313-24-000075.md) | [2,035](/filings/0000825313-26-000020.md) | [1,997](/filings/0000825313-25-000034.md) | [1,982](/filings/0000825313-25-000077.md) | [1,179](/filings/0000825313-25-000104.md) | [1,240](/filings/0000825313-26-000083.md) | [1,261](/filings/0000825313-26-000032.md) | [1,246](/filings/0000825313-26-000050.md) | [1,207](/filings/0000825313-26-000083.md) |
| Total liabilities | $m | [1.3](/filings/0000825313-25-000014.md) | [0.4](/filings/0000825313-24-000037.md) | [0.6](/filings/0000825313-24-000060.md) | [0.7](/filings/0000825313-24-000075.md) | [2.8](/filings/0000825313-26-000020.md) | [0.3](/filings/0000825313-25-000034.md) | [0.4](/filings/0000825313-25-000077.md) | [1.9](/filings/0000825313-25-000104.md) | [1.7](/filings/0000825313-26-000083.md) | [0.1](/filings/0000825313-26-000032.md) | [1.0](/filings/0000825313-26-000050.md) | [0.6](/filings/0000825313-26-000083.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [72.8 d](/filings/0000825313-26-000020.md) | [87.7](/filings/0000825313-25-000034.md) | [84.3 d](/filings/0000825313-25-000077.md) | [81.1 d](/filings/0000825313-25-000104.md) | [87.5 d](/filings/0000825313-26-000020.md) | [115](/filings/0000825313-26-000032.md) | [88.7 d](/filings/0000825313-26-000050.md) | [71.2 d](/filings/0000825313-26-000083.md) | [77.2 d](/filings/0000825313-26-000020.md) | [88.5](/filings/0000825313-26-000032.md) | [76.9 d](/filings/0000825313-26-000050.md) | [76.4 d](/filings/0000825313-26-000083.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 91,931,441 at 2026-09-30, from the cover of the [10-Q filed 2026-10-29](/filings/0000825313-26-000083.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 19:10 ET. No prices; not investment advice.